Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane O

MIEBO is the First and Only Prescription Eye Drop that Directly Targets Tear Evaporation, the Leading Cause of Dry Eye Disease

...

Related Keywords

New Jersey , United States , Canada , Canadian , American , Americans , Markowitz Jt , Andrew Stewart , Lomb Corporation , Facebook , Drug Administration , Instagram , Exchange Commission , Global Pharmaceuticals , Twitter , International Consumer , Linkedin , Prescribing Information , Visual Analog Scale , Canadian Securities Administrators , Eye Products Market Report , Global Analysis , Evaporative Dry Eye , Clinic Based Cohort , Ophthalmol Vis , Dry Eye , Randomized Phase , Markets ,